Acetylsalicylic acid Not Yet Recruiting Phase N/A Trials for EGFR T790M / Advanced Non Small Cell Lung Cancer / Non-Small Cell Lung Cancer Stage IIIB

IndicationsStatusPurposePhase
Not Yet RecruitingNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03532698Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)
NCT03543683Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC